An electrophysiological study of visual processing in spinocerebellar ataxia type 2 (SCA2)

. 2011 Mar ; 10 (1) : 32-42.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid20927662

Reports of visual functional impairment in spinocerebellar ataxia type 2 (SCA2) have been studied previously using pattern reversal visually evoked potentials (VEPs) with contradictory results. To provide additional evidence to this area, visual functions were studied using VEPs and event-related potentials (ERPs) in a group of ten patients with genetically verified SCA2. The electrophysiological examination included pattern reversal and motion-onset VEPs as well as visually driven oddball ERPs with an evaluation of a target and a pre-attentive response. In six patients, we found abnormal visual/cognitive processing that differed from normal values in latency, but not in the amplitude of the dominant VEP/ERP peaks. Among the VEPs/ERPs used, the motion-onset VEPs exhibited the highest sensitivity and showed a strong Spearman correlation to SCA2 duration (from r = 0.82 to r = 0.90, p < 0.001) and clinical state assessed by Brief Ataxia Rating Scale (from r = 0.71 (p = 0.022) to r = 0.80 (p < 0.001)). None of the VEP/ERP latencies showed a correlation to the triplet repeats of the SCA2 gene. In three patients, we did not find any visual/cognitive pathology, and one subject showed only a single subtle prolongation of the VEP peak. The observed visual/cognitive deficit was related to the subjects' clinical state and the illness duration, but no relationship to the genetic marker of SCA2 was found. From the VEP/ERP types used, the motion-onset VEPs seems to be the most promising candidate for clinical state monitoring rather than a tool for early diagnostic use.

Zobrazit více v PubMed

Brain Cogn. 2008 Dec;68(3):219-28 PubMed

Genetika. 2005 Jun;41(6):830-7 PubMed

Cerebellum. 2009 Dec;8(4):417-22 PubMed

Doc Ophthalmol. 2007 Mar;114(2):83-105 PubMed

Brain. 1997 Dec;120 ( Pt 12):2141-8 PubMed

Vision Res. 1995 Jan;35(2):197-205 PubMed

Neuroimage. 2005 Feb 1;24(3):874-86 PubMed

Mov Disord. 2009 Sep 15;24(12):1820-8 PubMed

J Neurol Sci. 1996 Oct;142(1-2):45-53 PubMed

J Neurol Sci. 2002 Jun 15;198(1-2):87-92 PubMed

Vision Res. 2006 Feb;46(4):536-44 PubMed

Cerebellum. 2008;7(2):115-24 PubMed

Vision Res. 2007 Jan;47(2):189-202 PubMed

J Neurol Sci. 2007 Dec 15;263(1-2):158-64 PubMed

Doc Ophthalmol. 2004 Sep;109(2):169-75 PubMed

Neurol Neurochir Pol. 2005 Jul-Aug;39(4):263-275 PubMed

Cerebellum. 2009 Sep;8(3):403-15 PubMed

Schizophr Res. 2008 Jul;102(1-3):320-8 PubMed

J Neurol Sci. 2010 Mar 15;290(1-2):22-6 PubMed

J Neurol. 1997 Feb;244(2):65-70 PubMed

Cerebellum. 2005;4(1):2-6 PubMed

Cerebellum. 2008;7(2):198-203 PubMed

Neuroreport. 2003 Oct 6;14(14):1799-802 PubMed

Spat Vis. 1997;10(4):433-6 PubMed

Vision Res. 2004 Jan;44(2):119-34 PubMed

Ann Neurol. 2005 Apr;57(4):505-12 PubMed

Cerebellum. 2009 Jun;8(2):127-9 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace